Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Pulmozyme |
| Active Ingredient: | Dornase alfa 1mg/mL |
| Dosage Form: | Solution for inhalation |
| New Zealand Sponsor: | Roche Products (NZ) Limited |
| Manufacturers: | Genentech Inc, California, United States of America Woodstock Sterile Solutions, Inc., Illinois, United States of America |
Dated this 22nd day of August 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).